Microarray Device for Functional Protein Inhibitor Screening

The patent combines structural information (protein immobilization on microarray) with functional information (detectable label on inhibitor showing binding activity) into a single integrated system. The microarray simultaneously provides spatial positioning of proteins and real-time detection of inhibitor binding through fluorescence signals, resolving the contradiction between obtaining structural data and performing functional screening.

The detectable label (fluorescent marker) serves as an intermediary that bridges the gap between the inhibitor molecule and the detection system. It allows the functional binding interaction between inhibitor and protein to be visually detected and quantified, enabling functional screening capability that was previously absent in conventional microarrays.

The patent creates a simplified copy of the functional screening capability found in expensive methods like Alphascreen®. By using a microarray format with immobilized proteins and detectably labeled inhibitors, it replicates the essential functional detection capability while using simpler, more cost-effective equipment and procedures that avoid the complexity of specialized instruments required by conventional methods.

The microarray uses disposable, inexpensive components (glass slides, printed proteins, fluorescent labels) to achieve functional screening, replacing the need for expensive, complex, and often reusable specialized equipment. Each microarray can be used once and then discarded, eliminating the need for costly instrument maintenance and calibration while providing comparable functional screening capability.

The patent segments the screening process into thousands of individual protein spots arranged in a grid pattern on a single microarray slide. Each spot contains a specific protein that can be screened independently, allowing high-throughput analysis of multiple proteins simultaneously while using minimal amounts of each protein and inhibitor, thus increasing productivity without proportionally increasing material consumption.

The patent transitions from linear or single-point screening to a two-dimensional array format, where proteins are arranged in spatial positions across the slide surface. This dimensional expansion allows parallel screening of hundreds or thousands of protein-inhibitor interactions simultaneously, dramatically increasing throughput while maintaining efficient use of reagents through the concentrated, localized nature of each interaction site.